Efficacy and Safety of Tixagevimab/Cilgavimab to Prevent COVID-19 (Pre-Exposure Prophylaxis): A Systematic Review and Meta-Analysis

Efficacy and Safety of Tixagevimab/Cilgavimab to Prevent COVID-19 (Pre-Exposure Prophylaxis): A Systematic Review and Meta-Analysis

Background: Tixagevimab/cilgavimab (TGM/CGM) are neutralizing monoclonal antibodies (mAbs) directed against different epitopes of the receptor-binding domain of the SARS-CoV-2 spike protein that have been considered as pre-exposure prophylaxis (PrEP). Objectives: This study seeks to assess the effic...

Full description

Bibliographic Details
Main Authors: Saad Alhumaid, Abbas Al Mutair, Jalal Alali, Nourah Al Dossary, Sami Hussain Albattat, Sarah Mahmoud Al HajjiMohammed, Fatimah Saad Almuaiweed, Maryam Radhi AlZaid, Mohammed Jaber Alomran, Zainab Sabri Alqurini, Ahmed Abduljalil Alsultan, Thamer Saeed Alhajji, Sukainah Mohammad Alshaikhnasir, Ali Al motared, Koblan M. Al mutared, Khalid Hajissa, Ali A. Rabaan
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Diseases
Subjects:
COVID-19
efficacy
evusheld
safety
SARS-CoV-2
tixagevimab/cilgavimab
Online Access:https://www.mdpi.com/2079-9721/10/4/118

Internet

https://www.mdpi.com/2079-9721/10/4/118

Similar Items